Session » Infection-related Rheumatic Disease: Poster Session

Date: Monday, November 9, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1355

Ankle Periarthritis, a New Sign for Chikungunya : Ultrasound Study of Joint Lesions at the Acute Phase of Chikungunya

9:00AM-11:00AM: Abstract Number: 1356

Autoimmune Manifestations in Hepatitis C: A Single-Centered Experience

9:00AM-11:00AM: Abstract Number: 1348

Clinical Characteristics and Outcomes of Patients with Septic Arthritis Treated without Surgery

9:00AM-11:00AM: Abstract Number: 1349

Clinical Characteristics and Outcomes of Septic Bursitis

9:00AM-11:00AM: Abstract Number: 1357

Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center

9:00AM-11:00AM: Abstract Number: 1358

Detection of a Unique Viral Infection in Salivary Glands of Sjögren’s Syndrome Patients and Viral-Mediated Recapitulation of Disease in Vivo

9:00AM-11:00AM: Abstract Number: 1352

How Frequently Does Tuberculosis Screening Test Become Positive in Rheumatic Patients Treated with ANTI-Tumor Necrosis Factor-ALPHA Therapy? an Analysis of Risk Factors

9:00AM-11:00AM: Abstract Number: 1351

Long-Term Efficacy of Latent Tuberculosis Infection Screening in Juvenile Idiopathic Arthritis Patients Prior to Anti-TNF Treatment in an Endemic Area

9:00AM-11:00AM: Abstract Number: 1343

Mortality Due to Sepsis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1350

Multi-Targeted Loop-Mediated Isothermal Amplification for Rapid Diagnosis of Osteoarticular Tuberculosis in 60 Minutes: Experience from North India

9:00AM-11:00AM: Abstract Number: 1359

Risk Factors for the Development of Gout in HIV Patients: A Retrospective Study

9:00AM-11:00AM: Abstract Number: 1345

The Impact of Prior Antibiotic Treatment on Culture Results of Patients with Septic Arthritis

9:00AM-11:00AM: Abstract Number: 1344

The Positive Synovial Fluid Culture: Septic Arthritis or Contamination?

9:00AM-11:00AM: Abstract Number: 1346

The Presentation and Outcomes of Surgically Treated Septic Arthritis: the Impact of Culture Results

9:00AM-11:00AM: Abstract Number: 1347

The Presentations and Outcomes of Prosthetic Joint Septic Arthritis: a Comparison of Culture-Positive and Culture-Negative Disease

9:00AM-11:00AM: Abstract Number: 1354

Whipple’s Disease: The Diagnostic Utility of Synovial Fluid Tropheryma Whipplei Polymerase Chain Reaction

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].